期刊文献+

替米沙坦联合小剂量吲达帕胺治疗老年原发性高血压的疗效观察 被引量:5

Curative effect of telmisartan combined with low-dose indapamide in the treatment of elderly patients with primary hypertension
下载PDF
导出
摘要 目的:探讨替米沙坦联合小剂量吲达帕胺治疗老年原发性高血压的疗效。方法:收治老年原发性高血压患者100例,随机分为对照组和观察组,对照组采用替米沙坦治疗,观察组采用替米沙坦联合小剂量吲达帕胺治疗,比较两组治疗效果。结果:观察组的治疗有效率和血压控制情况均明显优于对照组(P<0.05)。结论:替米沙坦联合小剂量吲达帕胺治疗老年原发性高血压的疗效显著。 Objective:To explore the curative effect of telmisartan combined with low-dose indapamide in the treatment of elderlypatients with primary hypertension.Methods:100elderly patients with primary hypertension were selected.They were randomlydivided into the control group and the observation group.The control group was treated with telmisartan.The observation group wastreated with telmisartan combined with low-dose indapamide.We compared the therapeutic effect of two groups.Results:In theobservation group,the treatment effectiveness and blood pressure control were significantly better than the control group(P<0.05).Conclusion:The curative effect of telmisartan combined with low-dose indapamide in the treatment of elderly patients withprimary hypertension was significant.
作者 李军象 颜永平 Li Junxiang;Yan Yongping(The Traditional Chinese Medicine Hospital of Yueyang City(Hunan Province),414000)
出处 《中国社区医师》 2017年第6期18-19,共2页 Chinese Community Doctors
关键词 替米沙坦 吲达帕胺 原发性高血压 Telmisartan Indapamide Primary hypertension
  • 相关文献

参考文献2

二级参考文献26

  • 1张其兵,王文敏.血压变异及其临床意义[J].昆明医科大学学报,2012,33(S1):244-246. 被引量:4
  • 2韩友萍.替米沙坦与苯磺酸左旋氨氯地平联用治疗原发性高血压的疗效观察[J].实用心脑肺血管病杂志,2010,18(12):1802-1803. 被引量:10
  • 3刘静,赵冬,王薇,刘军,孙佳艺,吴兆苏.北京自然人群代谢综合征发病率及影响因素的研究[J].心肺血管病杂志,2007,26(2):65-68. 被引量:14
  • 4Isomma BA. Major health hazard: the metabolic syndrome. Life Sei, 2003 ,73:2395-2411.
  • 5Schupp M, Janke J, Clasen R, et al. Angiotensin type 1 receptor blockers induce peroxisome prolfferator-activated reccptorgamm activity. Circulation ,2004,109: 2054-2057.
  • 6Nagel JM, Tietz AB, Goke B, et al. The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects. Metabolism , 2006,55 : 1149-1154.
  • 7Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation . Metab Syndr Relat Disord, 2004 ,2:82-104.
  • 8Shimamoto K, Miura T. Metabolic syndrome . Nippon Rinsho, 2009 ,67:771-776.
  • 9Nakayama S, Watada H, Mita T, et al. Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension. Hypertens Res, 2008,31:7-13.
  • 10Porto I, DiI Vito L, De Maria GL, et al. Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-xeaetive protein and endothelial progenitor cetls after acute coronary syndrome. Am J Cardiol,2009,103 : 1500-1505.

共引文献27

同被引文献28

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部